Trevena Announces Presentations of OLINVYK® Health Economic Models at ISPOR 2021

NEXT STORY
OMERS Announces Partnership with Gastro Health
PREV STORY
ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGE™

EMERYVILLE, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a ...

author_avatar
NASDAQ Market News

miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update

 MRG-106 granted orphan-drug status for the treatment of mycosis fungoides by U.S. Food and ...

author_avatar
NASDAQ Market News

Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused

- Broad Late-stage Development Plan in Place with Two Pivotal Trials and Patient Registry ...

author_avatar
NASDAQ Market News